PMID- 11724967 OWN - NLM STAT- MEDLINE DCOM- 20020110 LR - 20181113 IS - 0027-8424 (Print) IS - 1091-6490 (Electronic) IS - 0027-8424 (Linking) VI - 98 IP - 25 DP - 2001 Dec 4 TI - Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. PG - 14541-6 AB - Clonogenic multipotent mouse hematopoietic stem cells (HSCs) and progenitor cells are contained within the c-kit(+) (K) lineage(-/lo) (L) Sca-1(+) (S) population of hematopoietic cells; long-term (LT) and short-term (ST) HSCs are Thy-1.1(lo). c-kit is a member of the receptor tyrosine kinase family, a class of receptors that are important in the proliferation and differentiation of hematopoietic cells. To establish whether the Flk-2/Flt3 receptor tyrosine kinase was expressed on the most primitive LT-HSCs, we sorted highly purified multipotent stem and progenitor cells on the basis of Flk-2 surface expression and used them in competitive reconstitution assays. Low numbers of Flk-2(-) HSCs gave rise to long-term multilineage reconstitution in the majority of recipients, whereas the transfer of Flk-2(+) multipotent cells resulted in mostly short-term multilineage reconstitution. The KLS subset of adult mouse bone marrow was analyzed for Flk-2 and Thy-1.1 expression. Three phenotypically and functionally distinct populations were isolated: Thy(lo) Flk-2(-) (LT-HSCs), Thy(lo) Flk-2(+) (ST-HSCs), and Thy(-) Flk-2(+) multipotent progenitors. The loss of Thy-1.1 and gain of Flk-2 expression marks the loss of self-renewal in HSC maturation. The addition of Flk-2 antibody to the lineage mix allows direct isolation of LT-HSC from adult bone marrow as c-kit(+) lin(-) Sca-1(+) Flk-2(-) from many strains of mice. Fetal liver HSCs are contained within Flk-2(-) and Flk-2(+) KTLS cells. FAU - Christensen, J L AU - Christensen JL AD - Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Stanford, CA 94305-5324, USA. juliech@stanford.edu FAU - Weissman, I L AU - Weissman IL LA - eng GR - T32 AI007290/AI/NIAID NIH HHS/United States GR - P01 DK053074/DK/NIDDK NIH HHS/United States GR - CA42551/CA/NCI NIH HHS/United States GR - 5T32AI07290-16/AI/NIAID NIH HHS/United States GR - DK53074/DK/NIDDK NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. DEP - 20011127 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - 0 (Antigens, Ly) RN - 0 (Biomarkers) RN - 0 (Ly6a protein, mouse) RN - 0 (Membrane Proteins) RN - 0 (Proto-Oncogene Proteins) RN - 0 (Thy-1 Antigens) RN - EC 2.7.10.1 (Flt3 protein, mouse) RN - EC 2.7.10.1 (Proto-Oncogene Proteins c-kit) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 2.7.10.1 (fms-Like Tyrosine Kinase 3) SB - IM MH - Animals MH - Antigens, Ly/metabolism MH - Biomarkers MH - Cell Differentiation MH - Cell Separation/*methods MH - Fetus/cytology/immunology/metabolism MH - Hematopoiesis MH - Hematopoietic Stem Cell Transplantation MH - Hematopoietic Stem Cells/*cytology/immunology/*metabolism MH - Liver/cytology/immunology/metabolism MH - Membrane Proteins/metabolism MH - Mice MH - Mice, Congenic MH - Mice, Inbred C57BL MH - Phenotype MH - Proto-Oncogene Proteins/genetics/*metabolism MH - Proto-Oncogene Proteins c-kit/metabolism MH - Receptor Protein-Tyrosine Kinases/genetics/*metabolism MH - Thy-1 Antigens/metabolism MH - fms-Like Tyrosine Kinase 3 PMC - PMC64718 EDAT- 2001/11/29 10:00 MHDA- 2002/01/11 10:01 PMCR- 2002/06/04 CRDT- 2001/11/29 10:00 PHST- 2001/11/29 10:00 [pubmed] PHST- 2002/01/11 10:01 [medline] PHST- 2001/11/29 10:00 [entrez] PHST- 2002/06/04 00:00 [pmc-release] AID - 261562798 [pii] AID - 5627 [pii] AID - 10.1073/pnas.261562798 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14541-6. doi: 10.1073/pnas.261562798. Epub 2001 Nov 27.